What is your presentation about?
We will first discuss the state of disparities in hypoglycemia and diabetes technology by reviewing the literature on inequities by race/ethnicity and socioeconomics in the United States. Next, we will review the role of diabetes technology in effectively addressing hypoglycemia as well as the role that diabetes technology has on the psychosocial aspects of hypoglycemia. Finally, we will evaluate strategies to ensure equitable access to diabetes technology as a means to bridge gaps in glycemic outcomes including hypoglycemia.
What makes this topic important in 2022?
Disparities have been at front of mind for many over the last two to three years. This topic will add more nuance to the glycemic benefits of equitable diabetes technology access for all with practical tips on strategies to optimize technology access.
How did you become involved with this area of diabetes research or care?
I have had a long standing interest in identifying and addressing the drivers of disparities. Inequities in access to diabetes technology have resulted in worsening outcomes for historically excluded individuals and there is an urgency to address this inequity. Innovations in diabetes treatments are only truly innovative if they are able to help all with diabetes.
What are you most looking forward to at the 82nd Scientific Sessions?
It will be wonderful to be back in person for the first time in a few years and I am looking forward to the multiple sessions that the ADA has prioritized on disparities and equitable care for individuals with diabetes.